Pilot study on tolerability of specific immunotherapywith injective allergoid adsorbed on calcium phosphate in patients with respiratory allergy to house dust mite. - ND

• Conditions: allergic rhinoconjunctivitis with or without asthma; MedDRA version: 9.1Level: LLTClassification code 10039085Term: Rhinitis allergic

• Registration Number: EUCTR2007-003058-26-IT
• Lead Sponsor: OFARMA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10-05
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

-rhinoconjunctivitis with or without asthma due to allergy to house-dust mite

- age: 18-50 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- FEV < 75%

- atopic dermatitis or food allergy

- patients with previous serious anaphylactic reactions

- pregnancy and lactatio

- severe systemic diseases

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: tolerability evaluation;Secondary Objective: safety evaluation;Primary end point(s): tolerability evaluation